RecruitingPhase 4NCT05215132
Investigational MRI Clinical Software and Hardware
Study Evaluation of Feasibility and Reproducibility of Investigational MRI Clinical Software
Sponsor
Northwestern University
Enrollment
2,000 participants
Start Date
Dec 19, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Patients and healthy volunteers will be scanned in order to test new sequences.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria5
- • At least 18 years of age
- Able to complete the MR safety questionnaire.
- Able to comprehend and provide informed consent in English.
- When contrast is being administered: healthy volunteers with a GFR≥60 ml/min
- When contrast is being administered: patients with a GFR ≥30 ml/min
Exclusion Criteria8
- • When contrast is being administered: subjects with a GFR \< 30 ml/min
- When contrast is being administered: subjects with acute kidney injury
- When contrast is administered, allergy to gadolinium-containing contrast media
- Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions)
- Adults unable to consent
- Individuals who are not yet adults
- Pregnant or breastfeeding women
- Prisoners
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
RADIATIONMRI
1.5T or 3T MRI scanner (Siemens Medical Systems)
DRUGGadavist 2Ml Solution for Injection
Arm 1 and Arm 3 subjects will undergo this intervention (Gadavist 2Ml solution)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05215132